Argitalpenak (307) Ikertzaileren baten partaidetza izan duten argitalpenak

2024

  1. A nonlinear meccano for Alzheimer's emergence by amyloid β-mediated glutamatergic hyperactivity

    Neurobiology of Disease, Vol. 194

  2. Assessment of the Correlation and Diagnostic Accuracy between Cerebrospinal Fluid and Plasma Alzheimer’s Disease Biomarkers: A Comparison of the Lumipulse and Simoa Platforms

    International Journal of Molecular Sciences, Vol. 25, Núm. 9

  3. Autoimmune-associated epilepsy in an outpatient epilepsy clinic: A retrospective study

    Neurology Perspectives, Vol. 4, Núm. 1

  4. Combining imaging mass spectrometry and immunohistochemistry to analyse the lipidome of spinal cord inflammation

    Analytical and Bioanalytical Chemistry, Vol. 416, Núm. 8, pp. 1923-1933

  5. Defining a standard set of health outcomes for patients with relapsing-remitting multiple sclerosis

    Multiple Sclerosis and Related Disorders, Vol. 84

  6. Early beginning of alemtuzumab: changing the multiple sclerosis treatment paradigm. Interim analysis of the LEMVIDA study

    Neurologia, Vol. 39, Núm. 5, pp. 383-391

  7. La investigación del sistema nervioso: Su vertebración a través de la Sociedad Española de Neurociencia

    Encuentros multidisciplinares, Vol. 26, Núm. 76

  8. Neddylation orchestrates the complex transcriptional and posttranscriptional program that drives Schwann cell myelination

    Science Advances, Vol. 10, Núm. 15

  9. Systemic cellular migration: The forces driving the directed locomotion movement of cells

    PNAS Nexus, Vol. 3, Núm. 5

  10. Value contribution of blood-based neurofilament light chain as a biomarker in multiple sclerosis using multi-criteria decision analysis

    Frontiers in Public Health, Vol. 12

2023

  1. 27-hydroxycholesterol promotes oligodendrocyte maturation: Implications for hypercholesterolemia-associated brain white matter changes

    GLIA, Vol. 71, Núm. 6, pp. 1414-1428

  2. Alterations of Oligodendrocyte and Myelin Energy Metabolism in Multiple Sclerosis

    International journal of molecular sciences, Vol. 24, Núm. 16

  3. Cost-Analysis of Subcutaneous vs Intravenous Administration of Natalizumab Based on Patient Care Pathway in Multiple Sclerosis in Spain

    PharmacoEconomics - Open, Vol. 7, Núm. 3, pp. 431-441

  4. Endocannabinoid signaling in brain diseases: Emerging relevance of glial cells

    GLIA, Vol. 71, Núm. 1, pp. 103-126

  5. Hepatic levels of S-adenosylmethionine regulate the adaptive response to fasting

    Cell Metabolism, Vol. 35, Núm. 8, pp. 1373-1389.e8

  6. Local diffusion in the extracellular space of the brain

    Neurobiology of Disease, Vol. 177

  7. Microglia and meningeal macrophages depletion delays the onset of experimental autoimmune encephalomyelitis

    Cell death & disease, Vol. 14, Núm. 1, pp. 16

  8. Microglial phagocytosis dysfunction in stroke is driven by energy depletion and induction of autophagy

    Autophagy, Vol. 19, Núm. 7, pp. 1952-1981

  9. Monitoring response to disease-modifying treatment in multiple sclerosis

    Neurology Perspectives, Vol. 3, Núm. 2

  10. Planificación familiar en hombres y mujeres con esclerosis múltiple. Análisis del Registro Andaluz (2018-2022)

    Revista de neurologia, Vol. 76, Núm. 12, pp. 377-383